Rnd3 shows reduced expression in prostate cancer and seems to have a protective role against breast cancer [25]; however, increased Rnd3 expression has been found in other epithelial tumors and in metastatic melanoma cells [42], suggesting that the genetic background of cancer cells can influence the role of Rnd3 in trasformation. Here, RND3 is linked to prostate carcinoma.